ACETAdicet Bio, Inc.

$72M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$126M-4.6% YoY

Gross Profit

$31M24.5% margin

Operating Income

$1M1.1% margin

Net Income

-$564,000-0.4% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-1.9%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$648M

Stockholders' Equity

$396M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$126M	$132M	-4.6%
Gross Profit	$31M	$36M	-14.1%
Operating Income	$1M	$14M	-90.1%
Net Income	-$564,000	$8M	-106.8%

Revenue Segments

Human Health

$54M43%

Pharmaceutical Ingredients

$37M29%

Performance Chemicals

$35M28%

ACET Q4 2016 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena